1. Serum cholesterol in idiopathic and lupus-related protein-losing enteropathy
- Author
-
Ji Seon Oh, Seung-Jae Myung, Nah Ss, Bin Yoo, Moon Hb, Chang-Keun Lee, Yong-Gil Kim, and Jeong-Sik Byeon
- Subjects
Adult ,Male ,medicine.medical_specialty ,Cyclophosphamide ,Protein-Losing Enteropathies ,Gastroenterology ,Rheumatology ,immune system diseases ,Internal medicine ,Humans ,Lupus Erythematosus, Systemic ,Medicine ,Enteropathy ,Hypoalbuminemia ,skin and connective tissue diseases ,Aged ,Retrospective Studies ,Systemic lupus erythematosus ,Proteinuria ,Lupus erythematosus ,medicine.diagnostic_test ,business.industry ,Protein losing enteropathy ,Middle Aged ,medicine.disease ,Cholesterol ,Endocrinology ,Erythrocyte sedimentation rate ,medicine.symptom ,business ,medicine.drug - Abstract
Abstract The characteristics of protein-losing enteropathy were evaluated in patients with systemic lupus erythematosus. Among the patients with systemic lupus erythematosus ( n = 380) in a tertiary hospital, we reviewed the records of seven patients with generalized edema, hypoalbuminemia without proteinuria and positive results on 99mTc-labelled human serum albumin scintigrams. Patient characteristics and laboratory findings were compared between these seven patients and patients with lupus enteritis ( n = 15) or idiopathic protein-losing enteropathy ( n = 11). Compared with the lupus enteritis patients, the erythrocyte sedimentation rate and serum total cholesterol levels were significantly increased in patients with systemic lupus erythematosus–related protein-losing enteropathy. Compared with idiopathic protein-losing enteropathy patients, the level of serum total cholesterol was significantly increased, but the level of serum albumin was decreased in patients with systemic lupus erythematosus–related protein-losing enteropathy. Among patients with systemic lupus erythematosus–related protein-losing enteropathy, four patients had high serum total cholesterol levels (≥248 mg/dL) and achieved complete remission after receiving high doses of steroid treatment. However, three patients who had low serum total cholesterol levels (≤219 mg/dL) responded poorly to the steroid-only treatment, and could achieve complete remission only after 3 months of cyclophosphamide pulse treatment with concurrent corticosteroid therapy. The levels of serum total cholesterol are intriguing feature in systemic lupus erythematosus–associated protein-losing enteropathy patients.
- Published
- 2008
- Full Text
- View/download PDF